T. Kobayashi et al., EPIDERMAL GROWTH-FACTOR ELEVATES THE ACTIVITY LEVELS OF GLYCOLIPID SULFOTRANSFERASES IN RENAL-CELL-CARCINOMA CELLS, International journal of cancer, 55(3), 1993, pp. 448-452
Accumulation of sulfoglycolipids associated with markedly elevated lev
els of glycolipid-sulfotransferase activity was previously demonstrate
d in human renal-cell-carcinoma cells. To elucidate the regulatory mec
hanisms of sulfoglycolipid metabolism in renal-cell carcinoma, effects
of various growth factors on the sulfotransferase-activity levels wer
e investigated using a human renal-cell-carcinoma cell line, SMKT-R3.
Exogenous epidermal growth factor (EGF) significantly increased the ac
tivity levels of the sulfotransferases in a dose-dependent manner, but
did not change that of arylsulfatase A, which hydrolyzes sulfoglycoli
pids. Furthermore, metabolic labeling with S-35-sulfate revealed that
the addition of EGF to the culture medium of the cells resulted in an
increment of sulfoglycolipid synthesis. The expression of the EGF rece
ptor on SMKT-R3 cells was demonstrated by affinity cross-linking with
I-125-EGF. These observations suggest that EGF can regulate sulfotrans
ferase-activity levels in renal-cell-carcinoma cells, and function as
one of the regulatory factors of sulfoglycolipid synthesis in these ca
rcinoma cells. (C) 1993 Wiley-Liss, Inc.